SIA
ZBH icon

SkyView Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

SkyView Investment Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36
Closed -$4K – 502
2023
Q3 		$4K Buy
+36
New +$4.57K ﹤0.01% 424

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SkyView Investment Advisors's ZBH Position: Q4 2023 in Review

SkyView Investment Advisors sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 36 shares — an estimated $4K sold.

SkyView Investment Advisors first reported a position in ZBH in Q3 2023 and held it in 1 quarter. The position peaked at $4K in Q3 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • SkyView Investment Advisors reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 36 Zimmer Biomet shares in Q4 2023, an estimated $4K.
  • SkyView Investment Advisors first reported a position in Zimmer Biomet in Q3 2023 and held it in 1 quarter.
  • SkyView Investment Advisors's Zimmer Biomet position peaked at $4K in Q3 2023.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on SkyView Investment Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.